Collagen peptides
Collagen peptides has been studied in 63 papers since 2009: 28 trials in people, 13 in animals, 2 in cells, 20 reviews; 16 in the past year. The newest paper, Oct 18, 2026: “Dietary supplements to support healthy aging”.
63 papers study it126 findingsUpdated
Part of Bryan Johnson's BlueprintMore supplementsMore peptides
2 new papers in 30 daysSee all 64 papers on collagen peptides
At a glance
Collagen peptides extend lifespan in a worm study from one group; independent labs report increased bone mineral density in women in human trials and reduced oxidative stress in mice. Human trials differ on bone turnover markers, muscle strength and knee pain. Some authors are affiliated with companies, and a paper declares ties to GELITA.
126 findings in 44 papers from 2009 to 2026, 3 of them since April 2026
Independent labs found the same change in mice and people. 31 independent labs in 18 countries; 3 trials, none about aging, 1 with no results posted.
“CP supplementation over a 12-week period does not reduce knee pain in healthy, active, middle-aged to elderly individuals.”
4 of its findings point the other way.
- 31 independent labs in 18 countries
- 4 findings against
- 3 trials, none about aging, 1 with no results posted
- Funders: National Natural Science Foundation of China and others
- 25 of 121 findings with company ties
- Human trial28
- Animals12
- Model organisms1
- Cells2
Studies in people
See all 19 studies of collagen peptides in people19 studies gave collagen peptides to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
no change: Has no effect on systolic blood pressure-1 mmHg, 95% CI: -3, 2; p = 0.529 no change: Has no effect on diastolic blood pressure-1 mmHg, 95% CI: -2, 1; p = 0.449 no change: Has no effect on cognitive function | Randomized trial4 weeks | 56 peoplemiddle-aged and olderMidlife adults; Older adults; overweight/obesity | Food & function, Nov 25, 2025 |
up: Increases patellar tendon cross-sectional area up: Increases patellar tendon stiffness+661 ± 331 vs +247 ± 305 N/mm no change: Has no effect on muscle strength | Randomized trial12 weeks | 24 peoplemenbetween 40 and 60 yearsHealthy middle‐aged men, who were physically active or involved in recreational sport (> 120 min moderate activity and/or sport training per week) but naïve to lower limb resistance exercise | European journal of sport science, Apr 1, 2025 |
no change: Has no effect on squat jumpEG: d = -1.90 vs CG: d = -1.71 up: Improves musculoskeletal discomfort up: Improves countermovement jumpEG: d = -1.87 vs CG: d = -1.55 | Randomized trial24-week | 90 peopleBothbetween 45 and 65 years of ageAdults with regular non-professional sports habits and chronic osteoarticular pain | Biology of sport, Feb 12, 2025 |
no change: Has no effect on interstitial glucose95%CI for the effect size: -5.1, 30.0 mmol/(L*h); p-value = 0.159 up: Increases glycemic variability95%CI: 0.0, 0.2 mmol/L; p-value = 0.011 up: Increases insulinp-value = 0.005 | Randomized trialfour weeks | 56 peopleBothPatient cohorts | Clinical nutrition (Edinburgh, Scotland), Jan 22, 2025 |
up: Increases patellar tendon stiffness+15.4% ± 3.1% vs. +4.6% ± 3.0% up: Increases young's modulus+14.2% ± 4.0% vs. +3.4% ± 2.8% | Randomized trial10 weeks | 15 peoplefemale18 to 39 yearsProfessional female soccer athletes | Experimental physiology, Aug 29, 2024 |
What did studies of collagen peptides find?
87Studies of collagen peptides measured 87 outcomes; the most studied are bone mineral density (5 studies), muscle strength (4) and bone turnover markers (3).
Bone mineral density
upin humans2upin mice2upin reviews1
5 studies
Bone mineral density
upin humans2upin mice2upin reviews1
Collagen peptides increase bone mineral density in humans (primary, age-related reduction in BMD) (T-score spine: SCP +0.1 ± 0.26; CG -0.03 ± 0.18; ANCOVA p = 0.030; T-score femoral neck: SCP +0.09 ± 0.24; CG -0.01 ± 0.19; ANCOVA p = 0.003).
“In the SCP group (n = 66), BMD of the spine and of the femoral neck increased significantly compared to the control group (n = 65)”
Human trialprimary, age-related reduction in BMDdaily oral administrationbone5 g12 monthsfemalesn = 131
Nutrients
Collagen peptides increase bone mineral density in humans (particularly in postmenopausal women).
“as well as increases in BMD at whole body, femoral neck, and lumbar spine sites, particularly in postmenopausal women”
Reviewparticularly in postmenopausal womencollagen peptides
The Role of Collagen Supplementation in Bone Metabolism and Structure: A Scoping Review
Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine
Collagen peptides increase bone mineral density.
“Studies revealed that supplementing with collagen peptide significantly increased BMD in the femoral neck and spine.”
Reviewfemoral neck and spine
Efficacy of collagen peptide supplementation on bone and muscle health: a meta-analysis
Frontiers in nutrition
Collagen peptides increase bone mineral density in mice (ovariectomized).
“Twenty-six weeks after the OVX procedure, HC ingestion was still able to improve significantly bone mineral density (BMD)”
Animalsovariectomizedbone26 weeks
Hydrolyzed collagen improves bone status and prevents bone loss in ovariectomized C3H/HeN mice
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Collagen peptides increase bone mineral density in OVX mice.
“The BMD for OVX mice fed the diet including 25 g/kg of hydrolyzed collagen was significantly higher as compared to OVX mice.”
Animalsin OVX micefemur25 g/kg12 weeksfemales
Bone
Muscle strength
no changein humans4
4 studies
Muscle strength
no changein humans4
Collagen peptides showed no clear effect on muscle strength in humans.
“Twelve weeks’ high‐intensity resistance training enhanced muscle size as well as maximal and explosive strength in middle‐aged men, but these outcomes were unaffected by hydrolysed collagen supplementation.”
Human trial12 weeksmalesn = 24
European journal of sport science
Collagen peptides showed no clear effect on muscle strength in humans with resistance exercise (p > 0.05 for group × time interactions).
“MVT, pRTD, 10-RM and VL thickness all increased post-training (p < 0.05), but there were no group × time interactions (p > 0.05).”
Human trialwith resistance exercisehydrolysed collagen30 g HC and 50 mg vitamin C12 weeksmalesn = 20
European journal of sport science
Collagen peptides showed no clear effect on muscle strength in humans.
“However, there were no group × time (ANOVA, 0.596 ≤ p ≤ 0.743; Table; Figure ) or between‐group differences in percentage change for these maximum strength tests (unpaired t‐test, 0.703 ≤ p ≤ 0.929; 0.03 ≤ Effect size [ES] ≤ 0.13 [all] “Trivial”; Figure ).”
Human trial15 weeksn = 39
Acta physiologica (Oxford, England)
Collagen peptides showed no clear effect on muscle strength in humans during resistance training (0.684 ≤ p ≤ 0.929).
“Percentage changes in maximum strength (isometric or 1RM) did not differ between-groups (0.684 ≤ p ≤ 0.929).”
Human trialduring resistance trainingskeletal muscle15 g15 weeksmales
Acta physiologica (Oxford, England)
Collagen peptides showed no clear effect on muscle strength in humans (p = 0.247).
“Evaluation of isometric strength (p = 0.247), insulin-like growth factor 1 (p = 0.705) and the production of reactive oxygen species (pt1 = 0.229; pt2 = 0.741) revealed no significant interaction effect”
Human trial8 weeksmales
Journal of sports science & medicine
Collagen peptides showed no clear effect on muscle strength in humans with training.
“Muscle strength improved with training in all trials, but no additive effects of collagen were observed.”
Reviewwith training
Collagen Supplementation on Tendon-Related Structural and Performance Outcomes: A Systematic Review
Journal of functional morphology and kinesiology
Bone turnover markers
upin humans1downin humans1upin reviews1
3 studies
Bone turnover markers
upin humans1downin humans1upin reviews1
Collagen peptides decrease bone turnover markers in humans with osteopenia.
“prevention of aBMD decline and decrease of bone turnover after 12-mo supplementation with calcium, vitamin D with CPs.”
Human trialwith osteopenia5 g CPs, 500 mg calcium and 400 IU vitamin D3 per day12-mofemales
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry
Collagen peptides improve bone turnover markers in human subjects, particularly postmenopausal women.
“Collagen supplementation was associated with improvements in BTMs such as procollagen type I N-terminal propeptide and C-terminal telopeptide of type I collagen”
Reviewin human subjects, particularly postmenopausal womencollagen peptides
The Role of Collagen Supplementation in Bone Metabolism and Structure: A Scoping Review
Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine
Collagen peptides improve bone turnover markers (SMD 0.40–0.58).
“Collagen had no noticeable variance (I2 = 0%) and enhanced bone turnover indicators (SMD 0.40-0.58) and muscle performance (SMD 0.60 [0.05, 1.15]).”
Review
Efficacy of collagen peptide supplementation on bone and muscle health: a meta-analysis
Frontiers in nutrition
Patellar tendon stiffness
upin humans2
2 studies
Patellar tendon stiffness
upin humans2
Collagen peptides increase patellar tendon stiffness in humans (+661 ± 331 vs +247 ± 305 N/mm).
“the increase in k was greater in COL (+661 ± 331 N/mm) compared with PLA (+247 ± 305 N/mm) (t 18 = 2.91, p = 0.009, d = 1.31, Figure”
Human trial12 weeksmalesn = 24
European journal of sport science
Collagen peptides increase patellar tendon stiffness in humans with resistance exercise (k: +661 ± 331 N/mm vs +247 ± 305 N/mm (p = 0.009); E: +0.21 ± 0.13 GPa vs +0.09 ± 0.13 GPa (p = 0.018)).
“Similarly, k and E increased more in COL (k, +661 ± 331 N/mm and E, +0.21 ± 0.13 GPa) than PLA (k, +247 ± 305 N/mm, group × time, p = 0.009 and E, +0.09 ± 0.13 GPa, group × time, p = 0.018).”
Human trialwith resistance exercisehydrolysed collagenpatellar tendon30 g HC and 50 mg vitamin C12 weeksmalesn = 20
European journal of sport science
Collagen peptides increase patellar tendon stiffness in humans (+15.4% ± 3.1% vs. +4.6% ± 3.0%).
“Consequently, post hoc Student's unpaired t‐tests revealed that percentage changes in tendon stiffness [t(9) = 5.891, P < 0.001, +15.4% ± 3.1% vs. +4.6% ± 3.0%] and Young's modulus [t(9) = 4.910, P < 0.001, +14.2% ± 4.0% vs. +3.4% ± 2.8%] were higher in COL vs. PLA.”
Human trialpatellar tendon10 weeks
Experimental physiology
Collagen peptides increase patellar tendon stiffness in humans with pre-season soccer training (COL, +15.4% ± 3.1% (d = 0.81) vs. PLA, +4.6% ± 3.0% (d = 0.32), P = 0.002).
“The PT stiffness [COL, +15.4% ± 3.1% (d = 0.81) vs. PLA, +4.6% ± 3.0% (d = 0.32), P = 0.002] and Young's modulus [COL, +14.2% ± 4.0% (d = 0.65) vs. PLA, +3.4% ± 2.8% (d = 0.15), P = 0.004] increased more in COL than in PLA.”
Human trialwith pre-season soccer traininghydrolysed collagenpatellar tendon30 g10 weeksfemalesn = 11
Experimental physiology
Fat-free mass
upin humans2
2 studies
Fat-free mass
upin humans2
Collagen peptides increase fat-free mass in combination with resistance training (ΔCP-G = 3.42 ± 2.54 kg vs ΔP-G = 1.83 ± 2.09 kg).
“The main analysis showed that the specific collagen peptide supplementation exhibited a statistically significantly (p = 0.010) greater gain in fat free mass (ΔCP-G = 3.42 ± 2.54 kg) than placebo (ΔP-G = 1.83 ± 2.09 kg), as seen in.”
Human trialin combination with resistance training12-weekn = 61
International journal of environmental research and public health
Collagen peptides increase fat-free mass in humans (combined with resistance training) (ΔCP-G = 3.42 ± 2.54 kg vs ΔP-G = 1.83 ± 2.09 kg, p = 0.010).
“statistically significantly higher increase in fat free mass (p = 0.010) and decrease in fat mass (p = 0.023) in the CP-G compared with the P-G”
Human trialcombined with resistance training15 g daily12 weeksmalesn = 30
International journal of environmental research and public health
Collagen peptides increase fat-free mass in combination with resistance training (1.8 ± 1.6% vs. 0.9 ± 1.6%).
“shows that the TG had a statistically significantly higher increase of percentage fat-free mass compared to the CG (1.8 ± 1.6% vs. 0.9 ± 1.6%; d = 0.55).”
Human trialin combination with resistance training12 weeksn = 77
Nutrients
Collagen peptides increase fat-free mass in humans (p < 0.05).
“the increase in the TG was significantly higher in an RMANOVA analysis (p < 0.05).”
Human trial15 g daily12 weeksfemalesn = 77
Nutrients
Oxidative stress and ROS signaling
downin mice1downin rats1
2 studies
Oxidative stress and ROS signaling
downin mice1downin rats1
Collagen peptides decrease oxidative stress and ROS signaling in monoiodoacetate-induced knee osteoarthritis (in almost the same manner as nicotinamide riboside).
“The study determined that the treatment with NR in a similar dose with HC decreased blood/serum levels of oxidative stress biomarkers and the histological lesions in almost the same manner.”
Animalsin monoiodoacetate-induced knee osteoarthritis
Journal of clinical medicine
Collagen peptides decrease oxidative stress and ROS signaling in mice.
“CPs intake also significantly improved the antioxidative enzyme activities in skin”
Animalsskin8 weeksfemales
Nutrients
P1NP
no changein humans1upin humans1
2 studies
P1NP
no changein humans1upin humans1
Collagen peptides showed no clear effect on P1NP in humans (daily jumping exercise).
“No differences in serum P1NP concentrations were observed between JUMP+PLA and JUMP+COL (time x treatment, P = 0.58).”
Human trialdaily jumping exerciseserum20 g3 daysmalesn = 14
Bone
Collagen peptides increase P1NP in humans (primary, age-related reduction in BMD) (p = 0.007).
“P1NP increased significantly in the SCP group (p = 0.007)”
Human trialprimary, age-related reduction in BMDdaily oral administrationplasma5 g12 monthsfemalesn = 131
Nutrients
Procollagen type I N-terminal propeptide
no changein humans1upin humans1
1 study
Procollagen type I N-terminal propeptide
no changein humans1upin humans1
Collagen peptides showed no clear effect on procollagen type I N-terminal propeptide in humans.
“Post-hoc pairwise comparisons revealed that 30 g HC had a greater PINP response than 0 g HC (P = 0.002) and 15 g HC (P = 0.020), whereas 15 g HC did not differ from 0 g HC (P = 0.245).”
Human trial15 g7-h periodmalesn = 10
The Journal of nutrition
Collagen peptides increase procollagen type I N-terminal propeptide in humans.
“Post-hoc pairwise comparisons revealed that 30 g HC had a greater PINP response than 0 g HC (P = 0.002) and 15 g HC (P = 0.020), whereas 15 g HC did not differ from 0 g HC (P = 0.245).”
Human trial30 g7-h periodmalesn = 10
The Journal of nutrition
Collagen peptides showed no clear effect on procollagen type I N-terminal propeptide in humans (before high-intensity RE) (P = 0.225).
“there was no difference between 0 and 15 g HC (P = 0.225)”
Human trialbefore high-intensity REwith 50 mg vitamin C15 g vs 0 gmalesn = 10
The Journal of nutrition
Collagen peptides increase procollagen type I N-terminal propeptide in humans (before high-intensity RE) (267 ± 79 vs 235 ± 70 μg·L−1·h (P = 0.013) and 219 ± 88 μg·L−1·h (P = 0.002)).
“serum PINP concentration × time area under the curve (AUC) was greater for 30 g (267 ± 79 μg·L−1·h) than for 15 g (235 ± 70 μg·L−1·h, P = 0.013) and 0 g HC”
Human trialbefore high-intensity REwith 50 mg vitamin C30 gmalesn = 10
The Journal of nutrition
Musculoskeletal discomfort
upin humans1
1 study
Musculoskeletal discomfort
upin humans1
Collagen peptides improve musculoskeletal discomfort in humans (15 weeks post-intervention).
“The group that had taken the hydrolized collagen supplement gave more favorable evaluations regarding the reduction of their osteoarticular discomfort and the results of the program (see and ).”
Human trial15 weeks post-intervention24-week
Biology of sport
Collagen peptides improve musculoskeletal discomfort in humans (undergoing a 24-week training program) (72.1% vs 10.3%).
“After 24 weeks, 72.1% of the EG reported improved musculoskeletal discomfort, compared to only 10.3% of the CG.”
Human trialundergoing a 24-week training programhydrolyzed collagen enriched with minerals and vitamins10g24 weeksn = 90
Biology of sport
Squat jump
no changein humans1
1 study
Squat jump
no changein humans1
Collagen peptides showed no clear effect on squat jump in humans with training (EG: d = -1.90 vs CG: d = -1.71).
“Although SJ increased after 24 weeks of training for the entire population (p < 0.05, EG: d = -1.90, CG: d = -1.71), time × group differences were observed only within the female subgroup, where those who took the supplement showed higher values (p < 0.05, EG: d = -2.43, CG: d = -2.11; see ).”
Human trialwith training24-week
Biology of sport
Collagen peptides showed no clear effect on squat jump in humans (undergoing a 24-week training program).
“No significant differences were found in SJ between groups.”
Human trialundergoing a 24-week training programhydrolyzed collagen enriched with minerals and vitamins10g24 weeksn = 90
Biology of sport
Young's modulus
upin humans1
1 study
Young's modulus
upin humans1
Collagen peptides increase young's modulus in humans (+14.2% ± 4.0% vs. +3.4% ± 2.8%).
“Consequently, post hoc Student's unpaired t‐tests revealed that percentage changes in tendon stiffness [t(9) = 5.891, P < 0.001, +15.4% ± 3.1% vs. +4.6% ± 3.0%] and Young's modulus [t(9) = 4.910, P < 0.001, +14.2% ± 4.0% vs. +3.4% ± 2.8%] were higher in COL vs. PLA.”
Human trialpatellar tendon10 weeks
Experimental physiology
Collagen peptides increase young's modulus in humans with pre-season soccer training (COL, +14.2% ± 4.0% (d = 0.65) vs. PLA, +3.4% ± 2.8% (d = 0.15), P = 0.004).
“Young's modulus [COL, +14.2% ± 4.0% (d = 0.65) vs. PLA, +3.4% ± 2.8% (d = 0.15), P = 0.004] increased more in COL than in PLA.”
Human trialwith pre-season soccer traininghydrolysed collagenpatellar tendon30 g10 weeksfemalesn = 11
Experimental physiology
Mental health
upin humans1
1 study
Mental health
upin humans1
Collagen peptides improve mental health in humans (from baseline to 9 months).
“Regarding the VR-12, a significant group by time interaction was observed in mental component score values, F(6, 111) = 2.685, p =.027, ηp2 =.127, from baseline to 9 months, despite a violation of the assumption of normality.”
Human trialfrom baseline to 9 months6 months (with an optional 3 months, 9 months total)n = 86
Journal of the International Society of Sports Nutrition
Collagen peptides improve mental health in humans (over 3-9 months) (p = .017, ηp2 = .309).
“VR-12 mental component scores (MCS) improved with 10 g/d of CP over 3-9 months (p = .017, ηp2 = .309)”
Human trialover 3-9 months10 g/d
Journal of the International Society of Sports Nutrition
Pain
downin humans1
1 study
Pain
downin humans1
Collagen peptides decrease pain in HF exercisers from baseline to 6 months.
“Alternatively, when assessing the moderating effects of exercise frequency, a significant group by time interaction from baseline to 6 months in pain scores was observed in HF but not LF exercisers, F(4, 56) = 2.756, p =.037, ηp2 =.164, despite a violation of the assumption of normality.”
Human trialin HF exercisers from baseline to 6 months6 months (with an optional 3 months, 9 months total)
Journal of the International Society of Sports Nutrition
Collagen peptides decrease pain in humans (over 6 months) (p = .037, ηp2 = .164).
“pain (p = .037, ηp2 = .164) were observed with 10 g/d CP over 6 months, although pain only improved in high frequency exercisers (>180 min/week).”
Human trialover 6 months10 g/d
Journal of the International Society of Sports Nutrition
Physical function
upin humans1
1 study
Physical function
upin humans1
Collagen peptides improve physical function in humans (from baseline to 6 months).
“For the survey measures of the KOOS, a significant group by time interaction was observed in ADL scores, F(4, 110) = 2.926, p =.031, ηp2 =.096, from baseline to 6 months, although there was a violation of the assumption of normality and homogeneity of variance.”
Human trialfrom baseline to 6 months6 months (with an optional 3 months, 9 months total)n = 86
Journal of the International Society of Sports Nutrition
Collagen peptides improve physical function in humans (over 6 months) (p = .031, ηp2 = .096).
“Improvements in ADLs (p = .031, ηp2 = .096) and pain (p = .037, ηp2 = .164) were observed with 10 g/d CP over 6 months”
Human trialover 6 months10 g/d
Journal of the International Society of Sports Nutrition
β-CTX
no changein humans1
1 study
β-CTX
no changein humans1
Collagen peptides showed no clear effect on β-CTX in humans.
“no main effect of HC dose (P = 0.286, ηp2 = 0.127) and no dose × time interaction (P = 0.748, ηp2 = 0.031), that is, plasma β-CTX concentration decreased from −1 h (before HC ingestion and RE) to 6 h post-RE for all 3 interventions, with no difference between interventions”
Human trial7-h periodmalesn = 10
The Journal of nutrition
Collagen peptides showed no clear effect on β-CTX in humans (high-intensity RE) (P < 0.05 from -1 to +6 h).
“Plasma β-CTX concentration decreased from -1 to +6 h (P < 0.05), with no differences between interventions.”
Human trialhigh-intensity REfrom -1 to +6 hmalesn = 10
The Journal of nutrition
All 87Fewer
What is collagen peptides linked with?
2Studies link collagen peptides with 2 measures: hypertension and bone morphometric parameters.
Hypertension
downin reviews1
1 study
Hypertension
downin reviews1
Collagen peptides lower the risk of hypertension in metabolic syndrome review.
“The antihypertensive effect of collagen peptides (CP) is primarily linked to angiotensin-converting enzyme (ACE) inhibition”
Reviewin metabolic syndrome review
Nutrition research reviews
Bone morphometric parameters
mixedin rats1
1 study
Bone morphometric parameters
mixedin rats1
Collagen peptides are associated with bone morphometric parameters in rats (ovariectomized rats; compared with vehicle treatment).
“critical bone morphometric parameters exhibited significant differences between the LMWCP (400 mg/kg)-receiving and vehicle-treated rat groups.”
Animalsovariectomized rats; compared with vehicle treatmentlow-molecular-weightbone400 mg/kg
In Vitro and In Vivo Bone-Forming Effect of a Low-Molecular-Weight Collagen Peptide
Journal of microbiology and biotechnology
How this record changed
Summary written from the findings.